Overview of Health Canada and Medical Device Regulation
An overview of Health Canada's Medical Devices Directorate, the federal authority regulating the safety, efficacy, and quality of medical devices in Canada.
Overview
Summary of this regulator or jurisdiction and how it relates to market access.
Health Canada (Medical Devices Directorate) - Overview
The Medical Devices Directorate (MDD) within the Health Products and Food Branch of Health Canada is the federal authority responsible for regulating the safety, effectiveness, and quality of medical devices imported, distributed, or sold in Canada. This oversight spans the entire lifecycle of a device, from pre-market review to post-market surveillance.
Regulatory Framework and Risk Classification
Medical devices in Canada are governed under the Food and Drugs Act and the Medical Devices Regulations (CMDR). Devices are categorized into four distinct risk-based classes matching international frameworks:
- Class I (Lowest Risk): E.g., reusable surgical instruments, bandages, manual hospital beds.
- Class II (Low-to-Medium Risk): E.g., contact lenses, pregnancy test kits, infusion pumps.
- Class III (Medium-to-High Risk): E.g., orthopedic implants, glucose monitors, ultrasound imaging systems.
- Class IV (Highest Risk): E.g., pacemakers, defibrillators, structural heart valves.
Dual Licensing Mechanisms
Health Canada utilizes a two-tiered licensing approach to regulate products and supply chain actors:
- Medical Device Licence (MDL): A product-specific licence required for all Class II, III, and IV devices before they can be commercially sold. Manufacturers must also maintain a valid certificate under the Medical Device Single Audit Program (MDSAP).
- Medical Device Establishment Licence (MDEL): An organization-specific licence that regulates the supply chain. It is mandatory for Class I manufacturers (if distributing via a third party), as well as all importers and distributors of any class of medical devices.
Post-Market Surveillance and Vigilance
Once a product enters the Canadian market, Health Canada continuously monitors its performance. Manufacturers and importers are legally mandated to report serious adverse incidents (Mandatory Problem Reporting), handle field safety corrections, execute recalls, and submit annual summary reports to mitigate ongoing public health risks.
Articles & guides
Insight articles mapped to this region on ElendiLabs.
March 3, 2026
Navigating the Complexities of Health Product Classification at the Drug-Medical Device Interface
Health products that don't fit neatly into 'drug' or 'device' categories require careful classification by Health Canada to ensure appropriate regulatory oversight and risk mitigation. This process involves expert consultation and adherence to specific regulations.
Read article →
March 2, 2026
Fees for Human Drug Regulatory Activities in Canada
Health Canada charges fees for regulatory activities related to human drugs, including submission evaluations, master files, establishment licences, and the right to sell drugs, to support safety, efficacy, and quality assessments under the Fees in Respect of Drugs and Medical Devices Order.
Read article →
March 2, 2026
Health Canada Pathway for Licensing Natural Health Products with Modern Health Claims
Health Canada’s guidance outlines a risk-based approach for licensing natural health products (NHPs) making modern health claims, categorizing evidence into low, medium, and high risk levels to ensure safety and efficacy while providing a clear pathway for market access.
Read article →
March 1, 2026
Health Canada Guidance on Labelling of Pharmaceutical Drugs for Human Use
Health Canada’s 2014 guidance (revised 2015) provides principles and requirements for labelling pharmaceutical drugs to ensure safe, effective use and compliance with regulations, covering labels, inserts, and claims while promoting plain language and avoiding misleading information.
Read article →
January 19, 2026
Good Machine Learning Practice Principles for Medical Device Development – Health Canada Joint Guidance
Health Canada, together with the FDA and MHRA, published Good Machine Learning Practice (GMLP) principles to promote safe and effective development of machine learning-enabled medical devices, outlining 10 key principles covering multi-disciplinary expertise, data independence, performance assessment, risk management, transparency, and lifecycle monitoring to guide manufacturers and regulators.
Read article →
January 19, 2026
Guidance on Applications for Certificates of Pharmaceutical Product (CPP) – Health Canada Directive
Health Canada issues Certificates of Pharmaceutical Product (CPP) under WHO certification scheme to confirm regulatory status of drugs for export, with applications requiring specific forms, fees, product details, and compliance evidence; the guidance details eligibility, submission process, review timelines, and conditions for refusal or issuance to facilitate international trade.
Read article →
January 17, 2026
Pre-Market Guidance for Machine Learning-Enabled Medical Devices – Health Canada Recommendations
Health Canada’s pre-market guidance for machine learning-enabled medical devices (MLMD) provides recommendations on risk management, data quality, model training/validation, transparency, ongoing monitoring, and change management to ensure safety and effectiveness throughout the device lifecycle, aligning with international standards and addressing unique ML-specific challenges.
Read article →
January 17, 2026
Clinical Evidence Requirements for Medical Devices – Health Canada Guidance
Health Canada’s guidance outlines the clinical evidence expectations for Class II, III, and IV medical devices to demonstrate safety and effectiveness, emphasizing risk-based approaches, types of clinical data (literature, bench testing, animal studies, clinical investigations), and considerations for well-established technologies versus novel devices to support licence applications.
Read article →
January 17, 2026
Compliance and Enforcement Policy for Good Manufacturing Practices – Health Canada Overview
Health Canada’s Compliance and Enforcement Policy (POL-0001) outlines a risk-based approach to GMP inspections, compliance verification, and enforcement actions for drugs, active pharmaceutical ingredients, and medical devices, prioritizing higher-risk situations while promoting voluntary compliance through education, guidance, and proportionate responses to non-compliance.
Read article →
January 14, 2026
Health Canada – FDA eSTAR Pilot Program for Medical Device Submissions
Health Canada and the U.S. FDA launched a joint voluntary eSTAR pilot program to streamline medical device premarket submissions by using a single standardized electronic template compatible with both agencies, reducing administrative burden, improving review efficiency, and facilitating greater alignment between the two regulatory systems for Class II, III, and certain Class IV devices.
Read article →
January 14, 2026
Guidance on Cybersecurity for Medical Devices – Health Canada Expectations
Health Canada’s guidance outlines manufacturer expectations for incorporating cybersecurity throughout the medical device lifecycle, from design and risk management to post-market surveillance, emphasizing threat identification, secure architecture, vulnerability management, and secure updates to protect against cyber risks that could impact device safety and effectiveness.
Read article →
January 14, 2026
Guidance on Device Licence Applications for Diagnostic Ultrasound Systems and Transducers – Health Canada Notice
Health Canada’s notice clarifies the regulatory pathway for licensing diagnostic ultrasound systems and transducers as Class II medical devices under the Medical Devices Regulations, specifying required documentation, performance testing standards, labelling expectations, and considerations for transducers intended for various clinical applications to ensure safety and effectiveness in Canada.
Read article →
January 13, 2026
Licence Application Guidance for Implantable Cardiac Leads – Health Canada Overview
Health Canada’s guidance specifies additional evidence and considerations required for medical device licence applications or amendments involving implantable cardiac leads, including pacing leads, defibrillation leads, and associated adaptors or extensions, focusing on clinical performance, long-term safety, material biocompatibility, and fatigue/lead integrity testing to support high-risk Class IV classification.
Read article →
January 13, 2026
Other Regulatory Requirements for Medical Device Establishment Licence Holders – Health Canada Guidance
In addition to core MDEL obligations, holders must comply with broader requirements under the Food and Drugs Act and Medical Devices Regulations, including mandatory incident reporting, recall procedures, advertising restrictions, labelling compliance, and cooperation with Health Canada inspections and enforcement actions to ensure ongoing safety and regulatory adherence for Class II, III, and IV medical devices.
Read article →
January 12, 2026
Supporting Evidence for New or Amended Licence Applications – Class II, III, IV Medical Devices and IVDs – Health Canada Guidance
Health Canada’s guidance specifies the type and level of supporting evidence required for new or amended medical device licence applications for Class II, III, and IV devices including IVDs, emphasizing risk-based requirements for safety, effectiveness, quality, and clinical data proportionate to device risk and the nature of the amendment.
Read article →
January 12, 2026
What to Do When a Medical Device Establishment Licence (MDEL) is Suspended or Cancelled – Health Canada Guidance
When a Medical Device Establishment Licence (MDEL) is suspended or cancelled, the holder must immediately cease all regulated activities involving Class II, III, and IV devices, notify customers and suppliers, manage existing inventory through quarantine or recall, and cooperate with Health Canada to mitigate any health risks arising from non-compliance.
Read article →
January 11, 2026
Guidance for Manufacturers of HIV Diagnostic Kits – Health Canada Overview
Health Canada’s guidance outlines specific regulatory expectations and evidence requirements for manufacturers seeking licence approval for in vitro diagnostic kits intended to detect or confirm Human Immunodeficiency Virus (HIV) infection, covering performance standards, clinical evaluation, labelling, and post-market obligations to ensure reliable diagnostic accuracy and public health protection.
Read article →
January 10, 2026
Canada’s Participation in the International Medical Device Regulators Forum (IMDRF)
Health Canada actively participates in the International Medical Device Regulators Forum (IMDRF), a voluntary group of medical device regulators from ten member countries working to accelerate international regulatory convergence, harmonize technical requirements, and promote global alignment on premarket and post-market oversight to improve patient access to safe and effective medical devices.
Read article →
January 10, 2026
Guidance on Determining Significant Changes to Licensed Medical Devices – Health Canada Interpretation
Health Canada’s guidance document interprets what constitutes a ‘significant change’ to a licensed medical device under the Medical Devices Regulations, requiring manufacturers to assess design, manufacturing, labelling, and intended use modifications against specified criteria to determine if a new licence application, amendment, or administrative update is necessary to maintain regulatory compliance and device safety.
Read article →
January 10, 2026
Notice to Industry: Licensing Requirements for Medical Devices in Canada
Health Canada’s notice to industry clarifies licensing obligations for medical devices under the Medical Devices Regulations, emphasizing that most devices sold or imported into Canada require a valid medical device licence (except Class I devices), detailing application processes, timelines, and compliance expectations to ensure safety and effectiveness before market entry.
Read article →
January 10, 2026
Complete Application Requirements for New Medical Device Licences – Health Canada Implementation Guidance
Health Canada’s implementation guidance details the mandatory components and structure for complete new medical device licence applications under the Medical Devices Regulations, covering administrative forms, device description, labelling, quality management evidence, risk analysis, and supporting performance/safety data to facilitate efficient review and avoid screening deficiencies.
Read article →
January 10, 2026
Risk-Based Classification System for Non-In Vitro Diagnostic Medical Devices – Health Canada Guidance
Health Canada’s guidance document describes a risk-based classification system for non-IVD medical devices, assigning Class I to IV based on intended use, degree of invasiveness, duration of contact, and potential consequences of device failure, to ensure appropriate premarket scrutiny and regulatory controls.
Read article →
January 10, 2026
Examples of Software as a Medical Device Classification – Health Canada Guidance
Health Canada provides illustrative examples to help determine whether standalone software qualifies as a medical device and its corresponding risk classification under the Medical Devices Regulations, covering scenarios such as symptom trackers, diagnostic aids, treatment planning tools, and monitoring software to guide manufacturers on regulatory obligations.
Read article →
January 10, 2026
Importing and Exporting Health Products in Canada – Health Canada Requirements
Health Canada regulates the importation and exportation of drugs, medical devices, natural health products, and other health products under the Food and Drugs Act, requiring licences, permits, compliance with standards, and restrictions on certain products to ensure safety, quality, and efficacy during cross-border movement.
Read article →
January 10, 2026
2024 Annual Review of Medical Device Establishment Licences – Health Canada Summary
Health Canada’s 2024 annual MDEL review examined compliance of over 2,800 active Medical Device Establishment Licences, identifying common non-compliance issues such as inadequate record-keeping, incomplete incident reporting, and failure to implement corrective actions, leading to enforcement measures including suspensions and cancellations to protect public health.
Read article →
January 10, 2026
How to Search Canada’s MDALL Medical Device Licence Database
Learn how to search and verify medical device licenses in Health Canada’s public MDALL database. This step-by-step guide helps manufacturers, healthcare providers, and consumers confirm regulatory compliance and licensing status for Class II, III, and IV devices.
Read article →
January 10, 2026
Bed Rails in Hospitals and Long-Term Care – Health Canada Safety Facts
Health Canada’s fact sheet on bed rails highlights risks of entrapment, falls, and strangulation in hospitals and nursing homes, advising healthcare facilities to assess patient needs, use alternatives to physical restraints when possible, follow manufacturer instructions, ensure proper installation and maintenance, and report incidents to improve safety for vulnerable patients.
Read article →
January 10, 2026
Safe Use of Medical Devices – Health Canada Patient Guidance
Health Canada’s fact sheet educates patients on the safe use of medical devices, explaining device types, importance of following instructions, recognizing problems, reporting issues via the MedEffect system, and understanding that no device is risk-free but regulated for safety and effectiveness in Canada.
Read article →
January 9, 2026
Guidance on Medical Device Establishment Licensing in Canada – Health Canada Overview
Health Canada’s guidance details the requirements, application process, and obligations for obtaining and maintaining a Medical Device Establishment Licence (MDEL) for importers, distributors, and manufacturers of Class II, III, and IV medical devices, ensuring compliance with quality systems, record-keeping, and incident reporting to support safe distribution in Canada.
Read article →
January 8, 2026
Questions and Answers on Importation and Exportation under Good Manufacturing Practices – Health Canada
Health Canada provides Q&A guidance on how GMP requirements apply to the importation and exportation of drugs, active pharmaceutical ingredients, and medical devices, clarifying responsibilities for foreign sites, Canadian importers, quality agreements, and specific scenarios such as transit, personal importation, and investigational products to ensure consistent compliance.
Read article →
January 7, 2026
Labelling Requirements for Medical Devices Including In Vitro Diagnostic Devices – Health Canada Guidance
Health Canada’s labelling guidance specifies mandatory information that must appear on medical device labels and accompanying materials, including device identifier, manufacturer details, intended use, warnings, storage conditions, and special requirements for IVDs and certain device types, to ensure safe and effective use in compliance with the Medical Devices Regulations.
Read article →
January 7, 2026
Maintaining a Medical Device Establishment Licence (MDEL) – Health Canada Guidance
Health Canada requires MDEL holders to maintain ongoing compliance through annual renewals, prompt notification of changes, robust quality systems, accurate record-keeping, incident reporting, and readiness for inspections to ensure continued safe distribution of Class II, III, and IV medical devices in Canada.
Read article →
January 7, 2026
Cancellation of Medical Device Establishment Licences for Non-Compliance – Health Canada Bulletin
Health Canada may cancel a Medical Device Establishment Licence (MDEL) for serious or repeated non-compliance with the Food and Drugs Act and Medical Devices Regulations, including failure to maintain records, report incidents, or implement corrective actions, with prior notice and opportunity to respond unless immediate risk to health exists.
Read article →
January 5, 2026
Interim Guidance on Importing and Manufacturing Medical Gowns During COVID-19 – Health Canada
Health Canada’s interim guidance during the COVID-19 pandemic outlined flexible pathways for importing and manufacturing medical gowns (isolation gowns) to address shortages, including acceptance of non-traditional suppliers, alternative standards, labelling flexibilities, and risk-based oversight while maintaining minimum safety and performance expectations for healthcare use.
Read article →
January 5, 2026
Medical Device Licence Renewal Fees and Right to Sell – Health Canada Guidance
Health Canada’s guidance explains the annual licence renewal fees required to maintain the right to sell licensed Class II, III, and IV medical devices in Canada, detailing fee amounts, payment deadlines, exemptions, and consequences of non-payment, ensuring manufacturers understand obligations under the Medical Devices Regulations to avoid licence cancellation.
Read article →
January 5, 2026
Quality Management System Requirements for Medical Devices – Health Canada Guidance
Health Canada’s guidance outlines the expectations for manufacturers to establish and maintain a Quality Management System (QMS) compliant with ISO 13485 for medical devices sold in Canada, detailing documentation, risk management integration, process controls, and evidence required for Class II, III, and IV device licence applications to ensure consistent safety and performance.
Read article →
January 5, 2026
Guidance on Private Label Medical Devices – Health Canada Overview
Health Canada’s guidance clarifies regulatory obligations for private label (rebranded) medical devices, requiring the private label company to hold its own medical device establishment licence and, in most cases, its own device licence unless the original manufacturer’s licence covers the specific labelling and intended use, ensuring equivalent safety and performance standards under the Medical Devices Regulations.
Read article →
January 5, 2026
Software as a Medical Device – Health Canada Guidance Overview
Health Canada’s guidance on Software as a Medical Device (SaMD) defines regulatory classification, risk-based assessment, premarket requirements, and post-market obligations for standalone software intended for medical purposes, ensuring safety, effectiveness, and appropriate oversight for digital health technologies in Canada.
Read article →
January 4, 2026
Preparing an Application for Investigational Testing of In Vitro Diagnostic Devices – Health Canada Guidance
Health Canada’s guidance outlines the requirements and process for submitting an application for investigational testing authorization of in vitro diagnostic (IVD) devices in Canada, including when an ITA is needed, required documentation, risk-based considerations, ethics review coordination, and post-authorization obligations to ensure participant safety and data integrity during clinical performance studies.
Read article →
January 4, 2026
Classification of Products under the Food and Drugs Act in Canada – Health Canada Guidance
Health Canada’s guidance outlines how products are classified as food, drug, cosmetic, natural health product, medical device, or combination under the Food and Drugs Act, using factors like intended use, claims, mechanism of action, and presentation to determine the appropriate regulatory pathway and applicable requirements.
Read article →
January 3, 2026
Guidance for Manufacturers on Sterilization of Reusable Medical Devices – Health Canada Overview
Health Canada’s guidance provides manufacturers of reusable medical devices with detailed expectations for validating and documenting sterilization processes, including recommended methods, validation requirements, labelling of sterility assurance level, and instructions for use to ensure devices can be safely reprocessed between uses in compliance with the Medical Devices Regulations.
Read article →
January 3, 2026
How to Apply for a Medical Device Establishment Licence (MDEL) – Health Canada Guidance
Health Canada’s step-by-step guidance outlines the online application process for a Medical Device Establishment Licence (MDEL), including required information, supporting documents, quality system description, fees, and post-submission actions for importers, distributors, and manufacturers of Class II, III, and IV medical devices.
Read article →
January 2, 2026
Purchasing Licensed Medical Devices for Healthcare Use – Health Canada Guidance
Health Canada advises healthcare facilities and professionals to purchase only licensed Class II, III, and IV medical devices from authorized distributors or directly from licence holders, verify licensing status via MDALL, ensure proper documentation, and avoid unlicensed or counterfeit products to maintain patient safety and regulatory compliance in Canada.
Read article →
March 3, 2025
Navigating the Drug Approval Process in Canada: A Regulatory Overview
An analysis of how Health Canada's Health Products and Food Branch evaluates the safety, efficacy, and quality of therapeutic products before they reach the market.
Read article →